Osseous Metaplasia of Endometrium Managed with Oestrogens

Alka Goel

doi:10.1007/s13224-015-0801-y

Osseous Metaplasia of Endometrium Managed with Oestrogens

Alka Goel

In: The Journal of Obstetrics and Gynecology of India · 2015 · vol. 66(S2) , pp. 651–653 · doi:10.1007/s13224-015-0801-y · PMID:27803535 · W2227212222

article OA: bronze CC0 ⤵ 1 in-corpus citation

📄 Open PDF View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

This case report describes the management of endometrial osseous metaplasia using oestrogens following informed patient consent.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

This paper reports a case of endometrial osseous metaplasia that was managed with oestrogens, with informed consent obtained and no experimental drugs or diagnostic procedures reported. The key detail provided is that the patient received oestrogens for her condition, and the article notes the consent process explaining pros and cons. A limitation stated in the text is essentially the case-based nature of the report (single-patient description without broader study design details). This paper is centrally about endometriosis — it is not about endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works